Cargando…
Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy
AIMS: In recent decades, haemodynamic parameters have been estimated for risk stratification and determining treatment strategies for patients with non‐ischaemic dilated cardiomyopathy (DCM). In various invasive procedures, the cardiac pumping capability is defined as cardiac power output (CPO), whi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318402/ https://www.ncbi.nlm.nih.gov/pubmed/34042320 http://dx.doi.org/10.1002/ehf2.13446 |
_version_ | 1783730235379810304 |
---|---|
author | Morimoto, Ryota Mizutani, Takashi Araki, Takashi Oishi, Hideo Kimura, Yuki Kazama, Shingo Shibata, Naoki Kuwayama, Tasuku Hiraiwa, Hiroaki Kondo, Toru Furusawa, Kenji Okumura, Takahiro Murohara, Toyoaki |
author_facet | Morimoto, Ryota Mizutani, Takashi Araki, Takashi Oishi, Hideo Kimura, Yuki Kazama, Shingo Shibata, Naoki Kuwayama, Tasuku Hiraiwa, Hiroaki Kondo, Toru Furusawa, Kenji Okumura, Takahiro Murohara, Toyoaki |
author_sort | Morimoto, Ryota |
collection | PubMed |
description | AIMS: In recent decades, haemodynamic parameters have been estimated for risk stratification and determining treatment strategies for patients with non‐ischaemic dilated cardiomyopathy (DCM). In various invasive procedures, the cardiac pumping capability is defined as cardiac power output (CPO), which is calculated by multiplying cardiac output by the mean arterial pressure. Lower CPO values in advanced heart failure predict adverse outcomes. However, few studies discuss the prognostic value of CPO in mild‐to‐moderate phase patients. This study aimed to determine the value of the cardiac power index (CPI) obtained from the resting CPO for predicting the prognosis of patients with New York Heart Association Functional Class II or III DCM. METHODS AND RESULTS: From March 2000 to January 2020, a total of 623 cardiomyopathy patients were evaluated for haemodynamic parameters. Patients with secondary cardiomyopathy, ischaemic cardiomyopathy, valvular heart disease, and Class IV cardiomyopathy were excluded. A total of 176 DCM patients fulfilled the criteria for inclusion. Patients were 51.7 ± 12.5 years old (mean ± standard deviation) with a mean left ventricular ejection fraction of 32.1 ± 9.2%. The patients were divided into two groups by their median CPI (CPI < 0.52, low‐CPI; CPI ≥ 0.52, high‐CPI). No significant differences were found in the left ventricular end‐diastolic diameter, left ventricular ejection fraction, or pulmonary arterial wedge pressure between the groups. The probability of cardiac event‐free survival was significantly lower for low‐CPI than for high‐CPI groups by Kaplan–Meier analysis (P = 0.012), even with no significant difference between the high and low cardiac index groups (P = 0.069). Furthermore, Cox proportional hazards regression analysis revealed that, in addition to the CPI, the systolic and mean arterial pressure involved in CPI calculation were independent predictors of cardiac events. Indeed, among these factors, mean arterial pressure had the strongest prognostic ability. CONCLUSIONS: Although CPI is effective for stratifying DCM and predicting cardiac events in patients with Class II/III DCM, this prognostic value depends on mean arterial pressure. |
format | Online Article Text |
id | pubmed-8318402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83184022021-07-31 Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy Morimoto, Ryota Mizutani, Takashi Araki, Takashi Oishi, Hideo Kimura, Yuki Kazama, Shingo Shibata, Naoki Kuwayama, Tasuku Hiraiwa, Hiroaki Kondo, Toru Furusawa, Kenji Okumura, Takahiro Murohara, Toyoaki ESC Heart Fail Original Research Articles AIMS: In recent decades, haemodynamic parameters have been estimated for risk stratification and determining treatment strategies for patients with non‐ischaemic dilated cardiomyopathy (DCM). In various invasive procedures, the cardiac pumping capability is defined as cardiac power output (CPO), which is calculated by multiplying cardiac output by the mean arterial pressure. Lower CPO values in advanced heart failure predict adverse outcomes. However, few studies discuss the prognostic value of CPO in mild‐to‐moderate phase patients. This study aimed to determine the value of the cardiac power index (CPI) obtained from the resting CPO for predicting the prognosis of patients with New York Heart Association Functional Class II or III DCM. METHODS AND RESULTS: From March 2000 to January 2020, a total of 623 cardiomyopathy patients were evaluated for haemodynamic parameters. Patients with secondary cardiomyopathy, ischaemic cardiomyopathy, valvular heart disease, and Class IV cardiomyopathy were excluded. A total of 176 DCM patients fulfilled the criteria for inclusion. Patients were 51.7 ± 12.5 years old (mean ± standard deviation) with a mean left ventricular ejection fraction of 32.1 ± 9.2%. The patients were divided into two groups by their median CPI (CPI < 0.52, low‐CPI; CPI ≥ 0.52, high‐CPI). No significant differences were found in the left ventricular end‐diastolic diameter, left ventricular ejection fraction, or pulmonary arterial wedge pressure between the groups. The probability of cardiac event‐free survival was significantly lower for low‐CPI than for high‐CPI groups by Kaplan–Meier analysis (P = 0.012), even with no significant difference between the high and low cardiac index groups (P = 0.069). Furthermore, Cox proportional hazards regression analysis revealed that, in addition to the CPI, the systolic and mean arterial pressure involved in CPI calculation were independent predictors of cardiac events. Indeed, among these factors, mean arterial pressure had the strongest prognostic ability. CONCLUSIONS: Although CPI is effective for stratifying DCM and predicting cardiac events in patients with Class II/III DCM, this prognostic value depends on mean arterial pressure. John Wiley and Sons Inc. 2021-05-27 /pmc/articles/PMC8318402/ /pubmed/34042320 http://dx.doi.org/10.1002/ehf2.13446 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Articles Morimoto, Ryota Mizutani, Takashi Araki, Takashi Oishi, Hideo Kimura, Yuki Kazama, Shingo Shibata, Naoki Kuwayama, Tasuku Hiraiwa, Hiroaki Kondo, Toru Furusawa, Kenji Okumura, Takahiro Murohara, Toyoaki Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title | Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title_full | Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title_fullStr | Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title_full_unstemmed | Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title_short | Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
title_sort | prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318402/ https://www.ncbi.nlm.nih.gov/pubmed/34042320 http://dx.doi.org/10.1002/ehf2.13446 |
work_keys_str_mv | AT morimotoryota prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT mizutanitakashi prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT arakitakashi prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT oishihideo prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT kimurayuki prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT kazamashingo prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT shibatanaoki prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT kuwayamatasuku prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT hiraiwahiroaki prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT kondotoru prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT furusawakenji prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT okumuratakahiro prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy AT muroharatoyoaki prognosticvalueofrestingcardiacpowerindexdependsonmeanarterialpressureindilatedcardiomyopathy |